Nasdaq

Merit Medical Systems Initiates PREEMIE Study on Bloom Micro Occluder System for Treating Patent Ductus Arteriosus in Premature Infants

Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Merit Medical Systems, Inc. has announced the enrollment ...
Seeking Alpha

First Patient Enrolled in Merit Medical’s PREEMIE Study

SOUTH JORDAN, Utah, March 10, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (MMSI), a global leader of healthcare technology, today announced enrollment of the first patient in its multicenter, ...
Medscape

FDA Approves Abbott's Amplatzer PDA Occluder for Preemies

The US Food and Drug Administration (FDA) has approved the Amplatzer Piccolo Occluder (Abbott), the first medical device to treat patent ductus arteriosus (PDA) in premature babies weighing as little ...
Nasdaq

MMSI Announces Commencement of Patient Enrollment in PREEMIE Study

Merit Medical Systems, Inc. MMSI, on Monday, announced the enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder System for the treatment of patent ductus ...